DBVT insider filings

DBV Technologies S.A. — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-31. Screen DBVT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for DBVT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — DBV Technologies S.A.

FiledFormInsiderReported transactionsSource
2026-07-314Mohideen Pharis — Chief Medical OfficerSale (S): 464 @ $2.70EDGAR
2026-02-024Mohideen Pharis — Chief Medical OfficerSale (S): 534 @ $4.86EDGAR
2026-01-144BAKER BROS. ADVISORS LP — Director
Baker Bros. Advisors (GP) LLC — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0 · Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0EDGAR
2025-12-194EPIC Bpifrance
Bpifrance Participations SA
Bpifrance SA
Bpifrance Investissement S.A.S.
CAISSE DES DEPOTS ET CONSIGNATIONS
Sale (S): 2,036,990 @ $4.84 · Sale (S): 40,000 @ $5.28 · Sale (S): 1,292,103 @ $4.19EDGAR
2025-11-254Mohideen Pharis — Chief Medical OfficerSale (S): 6,496 @ $2.88 · Sale (S): 1,624 @ $2.77 · Grant/award (A): 44,000 @ $0 · Grant/award (A): 253,000 (derivative) @ $0EDGAR
2025-11-244Trapp Kevin Michael — Chief Commercial OfficerGrant/award (A): 55,000 @ $0 · Grant/award (A): 316,250 (derivative) @ $0EDGAR
2025-11-244Boucinha Virginie — Chief Financial OfficerGrant/award (A): 32,000 @ $0 · Grant/award (A): 192,000 (derivative) @ $0EDGAR
2025-11-244Tasse Daniel — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 964,000 (derivative) @ $0EDGAR
2025-07-314Mohideen Pharis — Chief Medical OfficerSale (S): 464 @ $2.22EDGAR
2025-05-274Mohideen Pharis — Chief Medical OfficerSale (S): 397 @ $1.84EDGAR
2025-03-314BAKER BROS. ADVISORS LP — Director, 10% owner
Baker Bros. Advisors (GP) LLC — Director, 10% owner
667, L.P. — Director, 10% owner
Baker Brothers Life Sciences LP — Director, 10% owner
BAKER FELIX — Director, 10% owner
BAKER JULIAN — Director, 10% owner
Grant/award (A): 2,299,656 (derivative) · Grant/award (A): 25,005,240 (derivative) · Grant/award (A): 2,299,656 (derivative) · Grant/award (A): 25,005,240 (derivative)EDGAR
2025-01-314Mohideen Pharis — Chief Medical OfficerSale (S): 600 @ $0.85EDGAR
2024-12-054Tasse Daniel — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 813,200 (derivative) @ $0EDGAR
2024-11-274Mohideen Pharis — Chief Medical OfficerSale (S): 342 @ $0.53 · Sale (S): 565 @ $0.57EDGAR
2024-11-254Mohideen Pharis — Chief Medical OfficerGrant/award (A): 35,000 @ $0 · Sale (S): 2,350 @ $0.54 · Grant/award (A): 215,000 (derivative) @ $0EDGAR
2024-11-254Boucinha Virginie — Chief Financial OfficerGrant/award (A): 19,000 @ $0 · Grant/award (A): 113,000 (derivative) @ $0EDGAR
2024-07-314Mohideen Pharis — Chief Medical OfficerSale (S): 1,785 @ $0.98EDGAR
2024-05-294Mohideen Pharis — Chief Medical OfficerSale (S): 382 @ $1.38 · Sale (S): 660 @ $1.36EDGAR
2024-03-114Tasse Daniel — CHIEF EXECUTIVE OFFICER, DirectorPurchase (P): 17,094 @ $0.83EDGAR
2024-02-084Ndu Adora — DirectorPurchase (P): 1,825 @ $0.89EDGAR
2023-12-194Mohideen Pharis — Chief Medical OfficerSale (S): 2,245 @ $1.74EDGAR
2023-11-224Boucinha Virginie — Chief Financial OfficerGrant/award (A): 19,000 @ $0 · Grant/award (A): 113,000 (derivative) @ $0EDGAR
2023-11-224Mohideen Pharis — Chief Medical OfficerGrant/award (A): 35,000 @ $0 · Grant/award (A): 215,000 (derivative) @ $0EDGAR
2023-11-224Tasse Daniel — Chief Executive Officer, DirectorGrant/award (A): 806,672 (derivative) @ $0EDGAR
2023-08-284MORRIS TIMOTHY E — DirectorPurchase (P): 12,000 @ $1.52EDGAR
2023-08-144Mohideen Pharis — Chief Medical OfficerGrant/award (A): 10,000 @ $0 · Grant/award (A): 17,500 @ $0 · Sale (S): 1,792 @ $2.88 · Sale (S): 469 @ $3.54 · Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 115,000 (derivative) @ $0EDGAR
2023-08-144Robitaille Sebastien — Chief Financial OfficerGrant/award (A): 8,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2023-08-144Tasse Daniel — Chief Executive Officer, DirectorGrant/award (A): 764,386 (derivative) @ $0EDGAR
2023-08-034SOLAND DANIEL B — DirectorPurchase (P): 15,000 @ $1.62EDGAR
2022-06-134BAKER BROS. ADVISORS LP — Director, 10% owner
667, L.P. — Director, 10% owner
BAKER JULIAN — Director, 10% owner
BAKER FELIX — Director, 10% owner
Baker Bros. Advisors (GP) LLC — Director, 10% owner
Baker Brothers Life Sciences LP — Director, 10% owner
Grant/award (A): 1,252,432 · Grant/award (A): 10,622,568 · Grant/award (A): 1,383,352 (derivative) · Grant/award (A): 11,732,979 (derivative)EDGAR
2021-11-244Mohideen Pharis — Chief Medical OfficerGrant/award (A): 8,700 @ $0 · Grant/award (A): 95,400 (derivative) @ $0EDGAR
2021-11-244Robitaille Sebastien — Chief Financial OfficerGrant/award (A): 5,000 @ $0 · Grant/award (A): 51,000 (derivative) @ $0EDGAR
2021-11-244Tasse Daniel — Chief Executive Officer, DirectorGrant/award (A): 274,000 (derivative) @ $0EDGAR
2021-06-114Ndu Adora — DirectorPurchase (P): 6,837 (derivative) @ $7.12EDGAR
2021-06-114Monges Viviane — DirectorPurchase (P): 5,000 (derivative) @ $7.12EDGAR
2021-06-114Rao Madduri Ravin — DirectorPurchase (P): 6,837 (derivative) @ $7.12EDGAR
2021-06-114SOLAND DANIEL B — DirectorPurchase (P): 6,837 (derivative) @ $7.12EDGAR
2021-06-114MORRIS TIMOTHY E — DirectorPurchase (P): 6,837 (derivative) @ $7.12EDGAR
2021-06-114DE ROSEN MICHEL — DirectorPurchase (P): 6,837 (derivative) @ $7.12EDGAR

Recent 8-K events — DBV Technologies S.A.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-028-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DBVT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs